Hypoplastic Left Heart Syndrome Clinical Trial
Official title:
Evaluation of Lomecel-B™ Injection in Patients With Hypoplastic Left Heart Syndrome (HLHS) : A Phase IIb Clinical Trial.
The purpose of this study is to test whether Lomecel-B™ works in treating patients with hypoplastic left heart syndrome (HLHS) and to gather additional information about the safety of Lomecel-B. Lomecel-B contains human mesenchymal stem cells (MSCs) as the active ingredient. MSCs are special cells in the body that are able to change into other types of cells, such as heart, blood, and muscle cells. MSCs are found in various tissues of the body, such as the bone marrow, which is the spongy tissue inside of your bones. Lomecel-B uses MSCs from bone marrow of unrelated young healthy donors. These are called "allogeneic", and do not require donor matching to the patient.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01215240 -
Prophylactic Peritoneal Dialysis Decreases Time to Achieve a Negative Fluid Balance After the Norwood Procedure
|
N/A | |
Completed |
NCT00513240 -
Erythropoetin Neuroprotection for Neonatal Cardiac Surgery
|
Phase 1/Phase 2 | |
Withdrawn |
NCT00156455 -
Sleep Disordered Breathing in Children With Single Ventricle Physiology
|
N/A | |
Terminated |
NCT01445041 -
Safety and Feasibility Study of Umbilical Cord Blood Cells for Infants With Hypoplastic Left Heart Syndrome
|
Phase 1 | |
Recruiting |
NCT04581668 -
Impact of NAVA Ventilation on Brain Oxygenation and Perfusion in Children With Congenital Heart Disease
|
N/A | |
Completed |
NCT01708863 -
A Prospective Study of Patients With Hypoplastic Left Heart Syndrome (HLHS) Following Stage II Surgical Palliation
|
||
Completed |
NCT01736956 -
Fetal Intervention for Aortic Stenosis and Evolving Hypoplastic Left Heart Syndrome
|
N/A | |
Recruiting |
NCT03406884 -
The CHILD Trial: Hypoplastic Left Heart Syndrome Study.
|
Phase 1 | |
Not yet recruiting |
NCT06461676 -
Study of Intramyocardial Injection of Ventrix Bio Extracellular Matrix (VentriGel) to Assess the Safety and Feasibility in Pediatric Patients With Hypoplastic Left Heart Syndrome (HLHS)
|
Phase 1 | |
Active, not recruiting |
NCT03079401 -
Mesoblast Stem Cell Therapy for Patients With Single Ventricle and Borderline Left Ventricle
|
Phase 1/Phase 2 | |
Completed |
NCT02306057 -
Fluid Balance in Children Undergoing Fontan Surgery
|
N/A | |
Terminated |
NCT01107990 -
Global and Regional Myocardial Strain and Power Output In Patients With Single Ventricles Using Novel MRI Techniques
|
||
Completed |
NCT01883076 -
Safety Study of Autologous Umbilical Cord Blood Cells for Treatment of Hypoplastic Left Heart Syndrome
|
Phase 1 | |
Completed |
NCT04056416 -
Physical Activity Promotion in Children and Adolescents With Single Ventricle Physiology (MedBike)
|
N/A | |
Completed |
NCT01656941 -
Genetic Determinants of Congenital Heart Disease Outcomes
|
||
Completed |
NCT00464100 -
Near-infrared Spectroscopy (NIRS) Neurodevelopmental Outcomes
|
||
Active, not recruiting |
NCT03779711 -
Intramyocardial Injection of Autologous Umbilical Cord Blood Derived Mononuclear Cells During Surgical Repair of Hypoplastic Left Heart Syndrome
|
Phase 2 | |
Recruiting |
NCT02781922 -
Cardiac Stem/Progenitor Cell Infusion in Univentricular Physiology (APOLLON Trial)
|
Phase 3 | |
Completed |
NCT01582529 -
SVRII Family Factors Study
|
||
Completed |
NCT00974025 -
Impact of Vitamin C on Endothelial Function and Exercise Capacity in Fontan-Palliated Patients
|
N/A |